How is the ARBAN Act different from the 2024 EPA chrysotile ban?

The EPA chrysotile ban targets only one of six asbestos types and phases out use over 12 years, allowing continued exposure during the transition. The ARBAN Act seeks an immediate, comprehensive ban on all six asbestos types: chrysotile, amosite, crocidolite, tremolite, anthophyllite, and actinolite. For mesothelioma victims, comprehensive legislation is far more protective because asbestos continues to pose risks regardless of which type causes exposure.

Why hasn't the US banned all asbestos like other developed nations?

The United States is behind 67-70 countries that have comprehensive asbestos bans. Political and economic factors have delayed comprehensive US legislation: asbestos industries have lobbied against bans, some manufacturers argued they could use asbestos 'safely,' and regulatory agencies prioritized phased approaches. The EPA chose a 12-year phase-out for chrysotile based on risk assessment and feasibility analyses, but advocates argue immediate bans better protect public health.

What are the six types of asbestos?

The six regulated types of asbestos are: (1) chrysotile—the most commonly used type, accounting for 95% of historical US asbestos imports; (2) amosite; (3) crocidolite; (4) tremolite; (5) anthophyllite; and (6) actinolite. All six types are carcinogenic and capable of causing mesothelioma. The EPA chrysotile ban addresses only one type, leaving five types legal for use in the US.

If ARBAN passes, does it help existing mesothelioma victims?

ARBAN prevents future exposures and would accelerate corporate accountability by closing loopholes. For existing mesothelioma victims, ARBAN strengthens the legal and regulatory environment by eliminating the argument that 'limited asbestos use is acceptable.' Comprehensive bans also increase settlement leverage because defendants can no longer claim ongoing exposures will occur. However, compensation comes through lawsuits and trust funds, not directly from legislation.

Which asbestos products are still legal in the US?

Currently, the United States still permits asbestos in specific products: gaskets, packing, cloth, electrical components, insulation, roofing materials, and other goods. The EPA has banned asbestos in some products (spray insulation, pipe insulation, fireproofing) but allows its use in many others. Imported products containing asbestos are still permitted unless specifically prohibited. The ARBAN Act would close these legal gaps.

How many other countries have comprehensive asbestos bans?

Between 67 and 70 countries have implemented comprehensive bans on all asbestos types. This includes most of Europe, Canada, Australia, Japan, and many other developed nations. The United States remains a significant global exception, as does Russia and several other nations. The contrast between international standards and US policy illustrates how mesothelioma prevention has fallen behind global best practices.

What happens if ARBAN passes Congress?

If ARBAN becomes law, the US would join most other developed nations with comprehensive asbestos bans. All manufacture, import, processing, distribution, and sale of asbestos would be prohibited. This would eliminate remaining legal uses and eliminate future exposures. Existing mesothelioma lawsuits would continue, and bankruptcy trusts would remain the primary compensation mechanism for victims exposed before the ban.

ARBAN Act 2025: Will Congress Finally Ban All Asbestos in America?

While 67–70 countries have already banned all forms of asbestos, the United States continues to allow six types of asbestos in commercial products. The EPA's 2024 chrysotile asbestos ban addressed only one type and phases out over 12 years—but Congress is considering more aggressive legislation. The Alan Reinstein Ban Asbestos Now (ARBAN) Act, named after a mesothelioma victim, seeks to eliminate all asbestos immediately, finally bringing the US into alignment with international public health standards.

Executive Summary

The ARBAN Act represents Congress's most comprehensive attempt yet to ban all asbestos in the United States. Named after Alan Reinstein, a mesothelioma victim, this legislation would immediately prohibit the manufacture, import, processing, and distribution of all six asbestos types. Unlike the EPA's 2024 chrysotile ban—which covers only one asbestos type and phases out over 12 years—ARBAN seeks immediate elimination of all asbestos. With 67–70 countries already implementing comprehensive bans and mesothelioma cases continuing to surge, the ARBAN Act addresses a critical gap in US public health law. For existing mesothelioma victims and their families, comprehensive legislation strengthens the legal environment for settlements and trust fund claims by closing loopholes that defendants have exploited for decades.

67–70

Countries with comprehensive asbestos bans

Types of asbestos still legal in the US

12 Years

EPA chrysotile ban phase-out timeline

3,000+

New mesothelioma cases annually in the US

Key Facts About the ARBAN Act and US Asbestos Policy

• ARBAN Act Target: Immediate comprehensive ban on all six asbestos types
• Named After: Alan Reinstein, mesothelioma victim and advocacy champion
• Current US Position: One of few developed nations without comprehensive ban
• EPA Chrysotile Ban (2024): Addresses only 1 of 6 asbestos types, 12-year phase-out
• Chrysotile Percentage: Accounts for ~95% of historical US asbestos imports
• Five Other Types: Amosite, crocidolite, tremolite, anthophyllite, actinolite remain legal
• Legal US Products: Gaskets, insulation, roofing, electrical components, brake linings
• Trust Fund Availability: $30+ billion in asbestos trust funds for victim compensation
• Litigation Strategy: ARBAN's passage would strengthen settlement leverage for victims
• International Standard: Complete bans reflect modern public health consensus

What Is the ARBAN Act and Why Was It Introduced in Congress?

The Alan Reinstein Ban Asbestos Now (ARBAN) Act is proposed federal legislation designed to accomplish what the EPA's phased approach cannot: an immediate, comprehensive elimination of all asbestos from American commerce. Named after mesothelioma victim Alan Reinstein, whose advocacy championed stronger asbestos protections before his death, the Act directly addresses a critical public health gap.

Unlike the EPA's regulatory authority—which is limited to individual chemicals or substances—Congressional legislation can impose sweeping, immediate bans. The ARBAN Act would prohibit the manufacture, import, processing, distribution, and sale of all six types of asbestos, with no phase-out period and no exemptions for "safe use" claims.

"The United States has a moral obligation to adopt comprehensive asbestos protections equivalent to those in other developed nations. When 67 countries have already eliminated all asbestos, allowing six types to remain legal creates an indefensible gap in our public health infrastructure. ARBAN addresses this gap directly and immediately."
— Paul Danziger, Founding Partner, Danziger & De Llano

Why Now?

Several factors have converged to make comprehensive asbestos legislation more viable in 2025–2026:

Global consensus: With 67–70 nations implementing comprehensive bans, the US looks increasingly isolated. Continued asbestos use undermines America's public health credibility internationally.
Ongoing mesothelioma epidemic: An estimated 3,000+ new mesothelioma cases are diagnosed in the US annually, with most resulting from decades-old exposures. The disease continues to claim lives at rates comparable to other developed nations where asbestos is banned.
EPA's limitations: The agency's 2024 chrysotile ban, while meaningful, highlighted the constraints of regulatory approaches. A ban on one asbestos type while five remain legal is seen as insufficient by many advocates.
Corporate accountability pressure: As bankruptcy trusts face depletion and defendants face ongoing litigation costs, comprehensive legislation becomes attractive as a pathway to finality and cost certainty.
Bipartisan disease focus: Mesothelioma affects both blue-collar workers and suburban residents; military veterans and civilians; Republicans and Democrats. The disease transcends traditional political divisions.

How Does the ARBAN Act Compare to the 2024 EPA Chrysotile Ban?

Understanding the difference between legislative and regulatory approaches is critical for mesothelioma victims. Both approaches aim to reduce asbestos exposure, but they operate differently and protect differently.

Aspect	EPA Chrysotile Ban (2024)	ARBAN Act (Proposed)
Scope	One asbestos type only (chrysotile)	All six asbestos types
Timeline	12-year phase-out period	Immediate prohibition
Exemptions	Some chemical uses allowed during transition	No exemptions; complete elimination
Authority	EPA regulatory power (TSCA)	Congressional legislation
Remaining Asbestos Types	Five types still legal: amosite, crocidolite, tremolite, anthophyllite, actinolite	All eliminated
International Alignment	Partial alignment; most nations allow no asbestos	Complete alignment with 67+ nations

Why Both Bans Matter

The EPA's 2024 chrysotile ban is important because chrysotile represents approximately 95% of all asbestos imported into the United States. Eliminating this type addresses the majority of ongoing exposure risk. However, the remaining five asbestos types are equally carcinogenic and equally capable of causing mesothelioma. The ARBAN Act acknowledges that partial protection is incomplete protection.

"A 12-year phase-out that allows five asbestos types to remain legal is progress, but it's not sufficient. Workers exposed to amosite or crocidolite during that 12-year window face the same mesothelioma risks. Comprehensive legislation provides the certainty that manufacturers and workers deserve."
— Paul Danziger, Founding Partner, Danziger & De Llano

Why Are 67–70 Countries Ahead of the United States on Asbestos Bans?

The global asbestos ban movement began in the 1970s with Scandinavian countries recognizing mesothelioma's catastrophic toll. Canada banned asbestos in 2018; the European Union in 2005; Australia in 2003. Yet the United States, despite having one of the world's largest asbestos litigation systems and the most extensive medical research infrastructure, has lagged behind.

Historical and Political Factors

Industry lobbying: Domestic asbestos manufacturers and companies using asbestos in products have consistently lobbied against comprehensive bans, arguing for "safe use" standards instead.
Regulatory fragmentation: The EPA operates within the Toxic Substances Control Act (TSCA), which requires risk assessment and feasibility analysis. Legislative bans can operate differently, based on public health principles rather than cost-benefit analyses.
Litigation vs. legislation: The US mesothelioma litigation system creates compensation through lawsuits and bankruptcy trusts, which may reduce political pressure for prevention. Other nations prioritized prevention rather than litigation-based compensation.
Asbestos exportation: The US has historically exported asbestos to developing nations, creating pressure to maintain domestic asbestos industries. International bans reduced this market, but domestic industries persisted.

The result is that corporate asbestos coverups and ongoing exposures continue in the US while global best practices have moved decisively toward comprehensive elimination.

Which Asbestos Types Are Still Legal in the United States?

Understanding the six asbestos types is essential for workers and their families, because all six pose mesothelioma risks. The EPA's 2024 chrysotile ban addresses only one:

The Six Asbestos Types

Chrysotile: The most commonly used asbestos type (95% of US imports). Found in insulation, brake linings, roofing, gaskets, and countless industrial products. Subject to EPA's 2024 ban but with 12-year phase-out.
Amosite: "Brown asbestos." Used in insulation, ceiling tiles, and industrial products. Still legal in the US. Equally carcinogenic as chrysotile.
Crocidolite: "Blue asbestos." Historically used in pipe insulation and fireproofing. Still legal in the US. One of the most potent mesothelioma-causing asbestos types.
Tremolite: Typically used as contamination in talc products and certain mineral ore. Still legal in the US in specific applications.
Anthophyllite: Rare in commercial applications but used in some industrial insulation and asbestos-cement products. Still legal in the US.
Actinolite: Similar to tremolite; used primarily as contamination in talc and mineral products. Still legal in the US.

The ARBAN Act would eliminate all six types immediately, leaving no legal asbestos products or uses in US commerce.

What Products Still Contain Legal Asbestos?

Despite decades of asbestos litigation and growing awareness of mesothelioma risks, multiple asbestos-containing products remain legal and in use:

Gaskets and packings: Industrial equipment seals
Insulation materials: Pipe insulation, block insulation, sprayed insulation (some restricted but not banned)
Roofing materials: Asbestos-cement shingles, roofing tar
Electrical components: Wire insulation, switchgear
Brake linings and clutch plates: Automotive applications
Talc products: Often contaminated with tremolite or actinolite
Imported products: Products manufactured overseas with asbestos, then imported into the US

For workers in manufacturing, automotive repair, building maintenance, and renovation, exposure to these products remains a present-day risk, not a historical issue.

How Would ARBAN Legislation Impact Mesothelioma Victims and Their Families?

While ARBAN would not directly provide compensation to existing mesothelioma victims, it would significantly strengthen the legal and settlement environment for ongoing cases.

Direct Litigation Benefits

Elimination of "safe use" arguments: Once Congress declares all asbestos illegal, defendants cannot argue that asbestos products were "safely manufactured" or that exposure was acceptable. This strengthens settlement pressure.
Increased corporate accountability: A comprehensive ban signals Congressional consensus that asbestos poses unacceptable risks. This shifts the litigation narrative away from isolated cases and toward systemic liability.
Bankruptcy trust prioritization: Companies with active trust funds would face pressure to provide generous settlement terms once all asbestos is illegal, eliminating arguments for conservative trust distributions.
Venue advantages: Juries in states with comprehensive asbestos protection laws view defendants less favorably than juries in states allowing asbestos. Federal legislation would create uniform, nationwide protection.

Long-Term Prevention

For families of future mesothelioma victims, ARBAN would provide the most important benefit: prevention. Workers and their families would be protected from occupational and environmental asbestos exposure, reducing future disease incidence.

"When Congress bans all asbestos, it sends a powerful message: this nation will no longer tolerate preventable mesothelioma. That message strengthens existing cases by eliminating every argument defendants use to minimize liability. It also protects the next generation from the same tragedy."
— Paul Danziger, Founding Partner, Danziger & De Llano

What Is the Likelihood That Congress Will Pass ARBAN?

Predicting Congressional action is always uncertain, but several factors suggest meaningful momentum:

Bipartisan support: Mesothelioma affects workers regardless of political party. Both Republican and Democratic constituencies include asbestos victims and occupational safety advocates.
International pressure: As more nations adopt comprehensive bans, the US isolation becomes more politically costly. International commerce and reputation create incentives to harmonize standards.
Legal precedent: The EPA's 2024 chrysotile ban provides proof that comprehensive asbestos restrictions are legally and scientifically defensible, reducing industry arguments about feasibility.
Economic efficiency: A single Congressional ban may be more efficient for manufacturers than navigating state-by-state regulations. Some industries may support uniform federal standards.

However, Congressional timelines are unpredictable, and industry opposition remains real. Mesothelioma victims and their families should not wait for ARBAN to become law before pursuing compensation. Existing lawsuits and trust fund claims are available now and should be pursued immediately.

How Can Mesothelioma Victims Access Compensation Today?

While the ARBAN Act represents important future protection, victims diagnosed today need immediate compensation. Multiple pathways exist, and experienced attorneys can help navigate all of them simultaneously.

Asbestos Litigation

Occupational asbestos exposure creates clear legal liability. Companies that manufactured, distributed, or used asbestos-containing products without adequate warnings can be held responsible for resulting mesothelioma. Settlements average $1–2 million, with trial verdicts frequently exceeding $5 million.

Asbestos Trust Funds

More than 60 companies have established bankruptcy trusts holding over $30 billion for mesothelioma victims. These funds operate independently of litigation and often provide rapid compensation. Experienced attorneys can file trust claims simultaneously with lawsuits, maximizing total recovery.

Veterans Benefits

Military veterans exposed to asbestos during service can access VA benefits, including disability compensation and healthcare. These benefits operate separately from litigation and can be combined with lawsuit settlements.

Our mesothelioma lawyers can evaluate your exposure history and identify all applicable compensation sources. We pursue lawsuits, trust fund claims, and veteran benefits simultaneously to maximize your family's recovery.

Frequently Asked Questions About the ARBAN Act

Q: What does ARBAN stand for?

ARBAN stands for "Alan Reinstein Ban Asbestos Now." It's named after Alan Reinstein, a mesothelioma victim and advocate who championed asbestos prevention before his death. The Act reflects his legacy by seeking comprehensive, immediate elimination of all asbestos from US commerce.

Q: If ARBAN becomes law, will existing mesothelioma cases be affected?

ARBAN would strengthen existing cases by eliminating defendants' arguments that asbestos was "safely used" or that exposure was acceptable. It would also increase settlement pressure by establishing Congressional consensus that all asbestos poses unacceptable risks. Existing lawsuits would continue and likely benefit from stronger legal leverage.

Q: Will ARBAN provide direct compensation to mesothelioma victims?

No. ARBAN is a ban on future asbestos use, not a compensation mechanism. Existing victims must pursue compensation through lawsuits and asbestos trust funds. However, ARBAN would strengthen these claims by providing regulatory/legislative backing for arguments about asbestos dangerousness and corporate liability.

Q: When will Congress vote on ARBAN?

Congressional timelines are unpredictable. ARBAN has been introduced in multiple Congressional sessions but has not yet passed both chambers. Mesothelioma victims should pursue compensation through current litigation and trust fund mechanisms rather than waiting for legislative action.

Q: What will happen to asbestos products already in buildings after ARBAN passes?

ARBAN would ban manufacture and import of asbestos products, but would not mandate removal of asbestos already installed in buildings. Existing asbestos-containing materials would remain until renovation, demolition, or voluntary removal. Workers handling these materials would still need asbestos awareness training and protective measures.

Q: How long will the EPA's chrysotile ban take to fully phase out?

The EPA's 2024 chrysotile ban has a 12-year phase-out period. This means chrysotile-containing products can continue to be manufactured and imported until 2036, creating a 12-year window during which new exposures could occur. ARBAN's immediate prohibition would eliminate this transition period.

Q: Should I wait for ARBAN to pass before pursuing a mesothelioma lawsuit?

No. Mesothelioma has a limited prognosis (median survival 12–21 months after diagnosis), and asbestos lawsuits and trust fund claims take time to resolve. You should pursue compensation immediately through existing legal mechanisms. If ARBAN passes, it will strengthen your case—but only if your case is already in the legal system.

Take Action Now—Don't Wait for Legislation

The ARBAN Act represents important future protection and will strengthen mesothelioma lawsuits if it passes. However, Congressional timelines are uncertain, and mesothelioma victims cannot afford to wait. Every day of delay reduces the time available to pursue compensation and allows defendants to develop case strategies.

A free case assessment can identify your compensation options, determine which asbestos trusts apply to your exposure, and estimate your settlement range. This information is crucial for making decisions about your family's financial future.

Related Resources

EPA Chrysotile Asbestos Ban 2024: What It Means for Mesothelioma Cases — Understand the EPA's regulatory approach
Asbestos Trust Funds: Complete Compensation Guide — Learn how to maximize trust fund claims
Find Mesothelioma Lawyers by State — Connect with experienced specialists
Free Case Assessment — Evaluate your compensation options

Learn More About Asbestos Legislation and History

Asbestos History Timeline — From ancient use to modern regulation
Corporate Asbestos Coverup — How manufacturers hid asbestos dangers
EPA Asbestos Regulations — Current regulatory status and policy

Sources:

US Environmental Protection Agency. (2024). Final Rule on Asbestos. Available at https://www.epa.gov/asbestos
International Ban Asbestos Secretariat. (2025). Global Asbestos Ban Timeline. Available at https://www.ibasecretariat.org/
US Congress. (2025). ARBAN Act Legislation Status. Available at https://www.congress.gov/
US Geological Survey. (2024). Asbestos Production, Imports, and Exports. Available at https://www.usgs.gov/
Agency for Toxic Substances and Disease Registry. (2024). Asbestos Toxicological Profile. Available at https://www.atsdr.cdc.gov/toxprofiles/tp61.pdf
CDC/NIOSH. (2024). Asbestos Exposure and Health Effects. Available at https://www.cdc.gov/niosh/topics/asbestos/
National Environmental Health Association. (2023). Occupational Asbestos Exposure Standards. Journal of Environmental Health.

Last updated: February 18, 2026